Magazine: Smart and connected packaging
With the recent conclusion of PharmaPack 2026, this month’s magazine is focused on the key messaging that emanated from the event. With…
Analysis
SLE: four trials to watch in 2026
Kisunla (donanemab-azbt) for the Treatment of Early Alzheimer’s Disease, US
Modeyso (dordaviprone) for the Treatment of Diffuse Midline Glioma, US
Trial acceleration: AI supports progress, relationships drive success
Nucala (mepolizumab) for the Treatment of Hypereosinophilic Syndrome (HES), UK
2026: The time for AI to really deliver
Speech biomarkers offer new lease of life to patient experience and trial retention
